Clinical Trials Directory

Trials / Completed

CompletedNCT00966901

Photoirritation and Photoallergic Potential of a New Nicotine Patch

Assessment of Photoirritation and Photoallergic Potential of a Newly Developed Nicotine Transdermal Therapeutic System (TTS) After Single and Multiple Application and Multiple UV Exposure in Healthy Subjects. A Standard Photocontact Allergenicity Assay.

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
43 (actual)
Sponsor
McNeil AB · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

An evaluation of the effects of UV exposure following the use of a new nicotine patch.

Detailed description

An evaluation on the phototoxic potential of a newly developed nicotine patch after a single dose application followed by UV exposure, and an evaluation on the photoallergenic potential of the new nicotine patch after multiple dose applications followed by UV exposure.

Conditions

Interventions

TypeNameDescription
DRUGNicotine Patch25 mg nicotine patch applied on the assigned marked site on the lower back or buttock. Induction (23 days): six treatment applications for 24 h. Challenge (five days): one treatment application for 24 h.
DRUGPlacebo PatchAs a positive control, a placebo patch applied on the assigned marked site on the lower back or buttock. Induction (23 days): six treatment applications for 24 h. Challenge (five days): one treatment application for 24 h.
DRUGNo Patch ControlAs a negative control, a marked site on the lower back or buttock was assigned as test area, but no patch was applied.
RADIATIONUVA and UVB irradiationAll three test sites exposed to UV radiation after patch removal. Induction: 10 J/cm2 UVA and 0.5 MED UVB, one treatment after first patch removal; and 3 MED UVB at the 5 following treatments. Challenge: 4 J/cm2 UVA and 0.5MED UVB, one treatment.( MED: Minimal Erythema Dose determined during screening)

Timeline

Start date
2005-08-01
Primary completion
2005-10-01
Completion
2005-10-01
First posted
2009-08-27
Last updated
2012-07-10

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00966901. Inclusion in this directory is not an endorsement.